Related Experiment Video
Updated: Jul 7, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
[Allergic bronchopulmonary aspergillosis: 3 cases].
Ferda Oner Erkekol1, Sevim Bavbek, Ozlem Göksel
1Division of Allergies, Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
Allergic bronchopulmonary aspergillosis (ABPA) affects 1-7.6% of asthma patients. Early diagnosis and treatment are crucial to prevent long-term lung damage.
Area of Science:
- Pulmonology
- Allergy and Immunology
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is a lung disease that affects patients with asthma.
- It occurs in 1-7.6% of asthma patients, highlighting its clinical significance.
Observation:
- ABPA symptoms and lab tests are often non-specific, leading to diagnostic delays.
- Delayed diagnosis and treatment can result in irreversible fibrotic lung disease.
Findings:
- This article reviews the clinical and laboratory features of ABPA.
- It also discusses the management strategies for ABPA, illustrated through three case studies.
Implications:
- Highlights the importance of considering ABPA in asthma patients with persistent or worsening symptoms.
- Emphasizes the need for timely diagnosis and appropriate management to prevent severe lung complications.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pneumonia III: Complications and Assessment
